- Home
- ENTX vs KOPN Comparison
ENTX vs KOPN Comparison
Compare ENTX & KOPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTX
- KOPN
- Stock Information
- Founded
- ENTX 2010
- KOPN 1984
- Country
- ENTX Israel
- KOPN United States
- Employees
- ENTX N/A
- KOPN N/A
- Industry
- ENTX Biotechnology: Biological Products (No Diagnostic Substances)
- KOPN Semiconductors
- Sector
- ENTX Health Care
- KOPN Technology
- Exchange
- ENTX Nasdaq
- KOPN Nasdaq
- Market Cap
- ENTX 69.6M
- KOPN 282.1M
- IPO Year
- ENTX 2018
- KOPN 1992
- Fundamental
- Price
- ENTX $1.85
- KOPN $1.31
- Analyst Decision
- ENTX Strong Buy
- KOPN Strong Buy
- Analyst Count
- ENTX 1
- KOPN 4
- Target Price
- ENTX $10.00
- KOPN $2.63
- AVG Volume (30 Days)
- ENTX 55.8K
- KOPN 2.4M
- Earning Date
- ENTX 05-09-2025
- KOPN 05-13-2025
- Dividend Yield
- ENTX N/A
- KOPN N/A
- EPS Growth
- ENTX N/A
- KOPN N/A
- EPS
- ENTX N/A
- KOPN N/A
- Revenue
- ENTX $99,000.00
- KOPN $44,266,305.00
- Revenue This Year
- ENTX N/A
- KOPN $21.20
- Revenue Next Year
- ENTX N/A
- KOPN $13.55
- P/E Ratio
- ENTX N/A
- KOPN N/A
- Revenue Growth
- ENTX 607.14
- KOPN 0.60
- 52 Week Low
- ENTX $1.30
- KOPN $0.56
- 52 Week High
- ENTX $3.35
- KOPN $2.33
- Technical
- Relative Strength Index (RSI)
- ENTX 40.63
- KOPN 43.13
- Support Level
- ENTX $1.78
- KOPN $1.16
- Resistance Level
- ENTX $2.00
- KOPN $1.40
- Average True Range (ATR)
- ENTX 0.16
- KOPN 0.15
- MACD
- ENTX -0.01
- KOPN -0.01
- Stochastic Oscillator
- ENTX 19.44
- KOPN 42.86
About ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
About KOPN Kopin Corporation
Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.